Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,640 | 470 | 81.9% |
| Consulting Fee | $1,120 | 1 | 10.6% |
| Education | $439.95 | 5 | 4.2% |
| Honoraria | $350.00 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,585 | 140 | $0 (2024) |
| UCB, Inc. | $1,380 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,077 | 53 | $0 (2024) |
| Janssen Biotech, Inc. | $956.12 | 49 | $0 (2024) |
| Amgen Inc. | $607.61 | 33 | $0 (2024) |
| Biofrontera Inc. | $509.69 | 5 | $0 (2024) |
| Dermavant Sciences, Inc. | $461.02 | 37 | $0 (2024) |
| LEO Pharma Inc. | $327.82 | 19 | $0 (2024) |
| PFIZER INC. | $271.69 | 14 | $0 (2024) |
| GENZYME CORPORATION | $255.76 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,593 | 87 | ABBVIE INC. ($407.84) |
| 2023 | $1,551 | 86 | AbbVie Inc. ($419.86) |
| 2022 | $1,315 | 62 | ABBVIE INC. ($646.43) |
| 2021 | $869.57 | 50 | AbbVie Inc. ($323.00) |
| 2020 | $667.26 | 32 | AbbVie Inc. ($166.36) |
| 2019 | $2,239 | 47 | UCB, Inc. ($1,254) |
| 2018 | $1,378 | 55 | Biofrontera Inc. ($474.98) |
| 2017 | $935.96 | 58 | AbbVie, Inc. ($143.22) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Dermatology | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Inflammation & Immunology | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,026 | 4,625 | $483,929 | $164,788 |
| 2022 | 18 | 2,349 | 4,792 | $555,594 | $193,289 |
| 2021 | 16 | 2,176 | 5,004 | $555,440 | $196,176 |
| 2020 | 16 | 2,298 | 4,501 | $561,384 | $183,844 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 641 | 995 | $128,405 | $57,768 | 45.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 429 | 640 | $95,584 | $24,903 | 26.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 27 | 32 | $38,305 | $16,578 | 43.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 150 | 175 | $30,903 | $12,280 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 134 | 148 | $27,040 | $11,392 | 42.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 356 | 2,289 | $80,115 | $11,123 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 91 | $17,417 | $7,463 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 85 | 85 | $16,392 | $5,780 | 35.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 14 | $9,942 | $4,606 | 46.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 35 | $16,100 | $4,329 | 26.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 32 | $10,301 | $3,993 | 38.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 46 | $3,602 | $1,778 | 49.4% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 14 | 15 | $7,156 | $1,709 | 23.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 28 | $2,667 | $1,087 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 726 | 1,049 | $135,373 | $60,397 | 44.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 464 | 639 | $95,276 | $25,230 | 26.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 37 | 41 | $49,079 | $22,345 | 45.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 172 | 197 | $34,718 | $13,415 | 38.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 158 | 178 | $36,134 | $13,287 | 36.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 371 | 2,169 | $75,859 | $10,557 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 109 | $20,863 | $9,922 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 113 | 113 | $21,562 | $7,699 | 35.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 12 | 12 | $13,434 | $6,155 | 45.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 32 | 44 | $20,240 | $5,391 | 26.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 13 | 15 | $10,652 | $5,032 | 47.2% |
About Dr. Michael Bryan, MD
Dr. Michael Bryan, MD is a Dermatology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356443196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bryan, MD has received a total of $10,550 in payments from pharmaceutical and medical device companies, with $1,593 received in 2024. These payments were reported across 477 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,640).
As a Medicare-enrolled provider, Bryan has provided services to 8,849 Medicare beneficiaries, totaling 18,922 services with total Medicare billing of $738,097. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Las Vegas, NV
- Active Since 09/02/2006
- Last Updated 01/31/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356443196
Products in Payments
- Cimzia (Drug) $1,361
- SKYRIZI (Biological) $1,097
- RINVOQ (Biological) $623.20
- COSENTYX (Biological) $621.91
- Ameluz (Drug) $474.98
- VTAMA (Drug) $461.02
- Humira (Biological) $453.08
- Enbrel (Biological) $431.87
- COSENTYX (Drug) $431.34
- TREMFYA (Drug) $353.97
- DUPIXENT (Biological) $282.74
- Otezla (Drug) $280.58
- EUCRISA (Drug) $250.10
- OPZELURA (Drug) $246.86
- Tremfya (Drug) $224.71
- REMICADE (Biological) $221.47
- Erivedge (Biological) $207.72
- HUMIRA (Biological) $206.12
- ENSTILAR (Drug) $156.56
- STELARA (Biological) $155.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Las Vegas
Mrs. Miriam Bettencourt, Md, MD
Dermatology — Payments: $1.2M
Harry Greenberg, Md, MD
Dermatology — Payments: $970,450
Dr. David Cotter, Md, Phd, MD, PHD
Dermatology — Payments: $703,353
Dr. Robert Strimling, Md, MD
Dermatology — Payments: $76,428
Dr. Candace Spann, M.d, M.D
Dermatology — Payments: $26,803
Dr. Clifton Hall, M.d, M.D
Dermatology — Payments: $17,129